IMRX vs. NUKZ
IMRX (Immuneering Corporation) is a stock, while NUKZ (Range Nuclear Renaissance ETF) is Energy Equities fund tracking the Range Nuclear Renaissance Index. Over the past year, IMRX returned 113.78% vs 27.91% for NUKZ. At a 0.25 correlation, their price movements are largely independent.
Performance
IMRX vs. NUKZ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IMRX achieves a -36.32% return, which is significantly lower than NUKZ's 7.57% return.
IMRX
- 1D
- 1.70%
- 1M
- -22.12%
- YTD
- -36.32%
- 6M
- -31.09%
- 1Y
- 113.78%
- 3Y*
- -24.01%
- 5Y*
- —
- 10Y*
- —
NUKZ
- 1D
- 1.59%
- 1M
- -5.07%
- YTD
- 7.57%
- 6M
- 4.81%
- 1Y
- 27.91%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
IMRX vs. NUKZ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
IMRX Immuneering Corporation | -36.32% | 199.09% | -62.46% |
NUKZ Range Nuclear Renaissance ETF | 7.57% | 56.57% | 60.11% |
Correlation
The correlation between IMRX and NUKZ is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Jan 24, 2024 | 0.25 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IMRX vs. NUKZ — Risk / Return Rank
IMRX
NUKZ
IMRX vs. NUKZ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Immuneering Corporation (IMRX) and Range Nuclear Renaissance ETF (NUKZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IMRX | NUKZ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | 0.00 | ||
| Sortino ratioReturn per unit of downside risk | +0.61 | ||
| Omega ratioGain probability vs. loss probability | 1.29 | 1.17 | +0.13 |
| Calmar ratioReturn relative to maximum drawdown | 1.98 | 1.70 | +0.29 |
| Martin ratioReturn relative to average drawdown | 3.30 | 4.11 | -0.81 |
Loading charts...
Drawdowns
IMRX vs. NUKZ - Drawdown Comparison
The maximum IMRX drawdown since its inception was -96.86%, which is greater than NUKZ's maximum drawdown of -33.03%. Use the drawdown chart below to compare losses from any high point for IMRX and NUKZ.
Loading charts...
Drawdown Indicators
| IMRX | NUKZ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.86% | -33.03% | -63.83% |
Max Drawdown (1Y)Largest decline over 1 year | -57.67% | -16.51% | -41.16% |
Max Drawdown (3Y)Largest decline over 3 years | -90.98% | — | — |
Current DrawdownCurrent decline from peak | -87.24% | -10.39% | -76.85% |
Average DrawdownAverage peak-to-trough decline | -77.61% | -6.06% | -71.55% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 34.56% | 6.80% | +27.76% |
Volatility
IMRX vs. NUKZ - Volatility Comparison
Immuneering Corporation (IMRX) has a higher volatility of 33.75% compared to Range Nuclear Renaissance ETF (NUKZ) at 11.24%. This indicates that IMRX's price experiences larger fluctuations and is considered to be riskier than NUKZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IMRX | NUKZ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 33.75% | 11.24% | +22.51% |
Volatility (6M)Calculated over the trailing 6-month period | 79.00% | 23.34% | +55.66% |
Volatility (1Y)Calculated over the trailing 1-year period | 124.22% | 30.46% | +93.76% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 114.45% | 32.94% | +81.51% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 114.45% | 32.94% | +81.51% |
Dividends
IMRX vs. NUKZ - Dividend Comparison
IMRX has not paid dividends to shareholders, while NUKZ's dividend yield for the trailing twelve months is around 0.85%.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
IMRX Immuneering Corporation | 0.00% | 0.00% | 0.00% |
NUKZ Range Nuclear Renaissance ETF | 0.85% | 0.91% | 0.09% |
Frequently Asked Questions
IMRX and NUKZ have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IMRX has higher volatility (33.75%) compared to NUKZ (11.24%). In terms of maximum drawdown, IMRX dropped -96.86% vs NUKZ's -33.03%.
IMRX currently has the higher Sharpe Ratio (0.92 vs 0.92), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IMRX and NUKZ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer